Gene · 4585
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of a MUC3B gene reconstructs the membrane mucin gene cluster on human chromosome 7. | PLoS One | 2022 | 36256656 | PubTator, text mining | PubMed |
| Statistical Evaluation of Metaproteomics and 16S rRNA Amplicon Sequencing Techniques for Study of Gut Microbiota Establishment in Infants with Cystic Fibrosis. | Microbiol Spectr | 2022 | 36255300 | PubTator, text mining | PubMed |
| Intramuscular myxoma of the left thigh: A case report. | Int J Surg Case Rep | 2022 | 36252547 | PubTator, text mining | PubMed |
| Low-grade fibromyxoid sarcoma of the vulva presenting as a cystic mass: A case report and review of literature. | Int J Surg Case Rep | 2022 | 36252544 | PubTator, text mining | PubMed |
| Cancer-derived small extracellular vesicles: emerging biomarkers and therapies for pancreatic ductal adenocarcinoma diagnosis/prognosis and treatment. | J Nanobiotechnology | 2022 | 36242076 | PubTator, text mining | PubMed |
| Understanding the extracellular vesicle surface for clinical molecular biology. | J Extracell Vesicles | 2022 | 36239734 | PubTator, text mining | PubMed |
| Molecular Mechanisms Driving the Formation of Brain Metastases. | Cancers (Basel) | 2022 | 36230886 | PubTator, text mining | PubMed |
| Expression of MUC16/CA125 Is Associated with Impaired Survival in Patients with Surgically Resected Cholangiocarcinoma. | Cancers (Basel) | 2022 | 36230626 | PubTator, text mining | PubMed |
| Synthesis and biomedical applications of mucin mimic materials. | Adv Drug Deliv Rev | 2022 | 36228896 | PubTator, text mining | PubMed |
| [Salivary gland tumors-an overview : Advances in molecular characterization: Part I]. | Pathologie (Heidelb) | 2022 | 36227346 | PubTator, text mining | PubMed |
| Epigenome-Wide Study Identifies Epigenetic Outliers in Normal Mucosa of Patients with Colorectal Cancer. | Cancer Prev Res (Phila) | 2022 | 36219239 | PubTator, text mining | PubMed |
| Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non-muscle-invasive Bladder Cancer. | Eur Urol | 2022 | 36210217 | PubTator, text mining | PubMed |
| In vitro and ex vivo models for evaluating vaginal drug delivery systems. | Adv Drug Deliv Rev | 2022 | 36208729 | PubTator, text mining | PubMed |
| Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance. | Nat Commun | 2022 | 36207323 | PubTator, text mining | PubMed |
| Urine exosomes as biomarkers in bladder cancer diagnosis and prognosis: From functional roles to clinical significance. | Front Oncol | 2022 | 36203422 | PubTator, text mining | PubMed |
| Efficacy and Safety of Pyrotinib in Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Multicenter, Retrospective, Real-World Study. | Onco Targets Ther | 2022 | 36199295 | PubTator, text mining | PubMed |
| The Role of Gender-Related Immune Genes in Childhood Acute Myeloid Leukemia. | Biomed Res Int | 2022 | 36193320 | PubTator, text mining | PubMed |
| Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy. | Nat Commun | 2022 | 36192482 | PubTator, text mining | PubMed |
| Immune landscape and risk prediction based on pyroptosis-related molecular subtypes in triple-negative breast cancer. | Front Immunol | 2022 | 36189269 | PubTator, text mining | PubMed |
| A rapid and durable response to larotrectinib in a patient with NTRK fusion-positive secretory carcinoma originating from the external auditory canal. | Int Cancer Conf J | 2022 | 36186229 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4585/papers?page=43